JOP. 2011 Mar 9;12(2):110-3.

Treatment for refractory pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.

Source

Oncology Unit, Third Department of Medicine, Sotiria General Hospital, Athens Medical School. Athens, Greece.

Abstract

While gemcitabine-based regimens are currently accepted as the standard first-line treatment of patients with locally advanced or metastatic pancreatic adenocarcinoma, there is no consensus regarding treatment in the second-line setting. This review is an update from the 2011 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium regarding recent developments in the treatment of refractory pancreatic cancer, as these were presented in Abstracts #237 and #272 of the meeting.

PMID:: 21386632; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

Congresses

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

JOP. Journal of the Pancreas (Online)

Medical

Pancreatic Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review What options are available for refractory pancreatic cancer? [JOP. 2012]
Review What options are available for refractory pancreatic cancer?
Choi M, Kim R, Saif MW. JOP. 2012 Mar 10; 13(2):163-5. Epub 2012 Mar 10.
Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. [JOP. 2011]
Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Chang BW, Saif MW. JOP. 2011 Mar 9; 12(2):101-5. Epub 2011 Mar 9.
First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. [JOP. 2011]
First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Oberstein PE, Saif MW. JOP. 2011 Mar 9; 12(2):96-100. Epub 2011 Mar 9.
Review Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. [JOP. 2011]
Review Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Makrilia N, Syrigos KN, Saif MW. JOP. 2011 Jul 8; 12(4):351-4. Epub 2011 Jul 8.
Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. [JOP. 2011]
Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Saif MW. JOP. 2011 Mar 9; 12(2):106-9. Epub 2011 Mar 9.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Treatment for refractory pancreatic cancer. Highlights from the "2011 ASCO Gastr...
Treatment for refractory pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
JOP. 2011 Mar 9 ;12(2):110-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: